The World Health Organization estimates that between 7 and 8 million people are infected by *Trypanosoma cruzi*, the etiologic agent of Chagas disease ([@B13]). Rural areas of 21 countries of the Latin American sub-continent from Mexico to the Southern Cone, are the traditionally recognised endemic regions for Chagas disease. Progress in vector transmission control, as well as in blood borne transmission control in endemic countries, have gradually changed the epidemiology of the disease. The Pan American Health Organization has certified the elimination of household transmission of the parasite from Uruguay (1997), Chile (1999), Brazil (2006), and Paraguay (2013); however, household transmission still occurs in the other countries of the Latin American sub-continent ([@B9]). Brazil has eradicated its main domiciliary vector, the *Triatoma infestans*. Extensive serosurveys among children have confirmed the elimination of transmission. In the state of São Paulo, elimination of transmission was achieved in the 1970s ([@B2], Ostermayer et al. 2011).

In addition to the successful elimination of household vector transmission, Brazil has greatly reduced, if not eliminated, transmission by blood and blood product transfusion, and by organ and tissue donation. Mandatory screening of blood and organ donors has become mandatory since 1994. However, the zoonotic transmission cycle still occurs, involving wild rodents, marsupials and other mammals of the South American fauna. Humans may accidentally be exposed to the zoonotic cycle while conducting outdoors activities in forest areas, such as camping, fishing, or logging, or by the consumption of contaminated food, particularly wild fruit juices ([@B6]). Between 2004-2014, over 1700 cases of acute Chagas disease were reported in 123 outbreaks, mainly in the Brazilian Amazon. Approximately 100-150 new cases of acute Chagas disease are reported every year in Brazil. The vast majority of these cases are related to foodborne transmission through the consumption of products containing non-pasteurised "açaí" or "bacaba", Amazonian regional fruits, contaminated with infected triatominae or with secretions from the anal glands of marsupials ([@B6], [@B4]).

Migration of chronically infected individuals has brought the disease to some developed countries in North America, Western Europe and Asia ([@B10]). Within South America, migrants continuously leave rural areas for the cities, a movement that may potentially include Chagas carriers. The city of São Paulo is the largest city in South America. It attracts migrants from all over the Latin American sub-continent. It is estimated that 300,000 Bolivian immigrants live in the city. The prevalence of the infection in Bolivia has been estimated at 6.8% ([@B7]. This large population from a region where the infection remains endemic may pose an additional burden on the Brazilian public health system and on national blood and organ donation programs. The aim of the present study was to assess the prevalence of *T. cruzi* infection in a sample of Bolivian immigrants living in downtown São Paulo and attending primary care clinics located in central São Paulo. This study is part of a larger research project designed to understand the access to health care by the Bolivian immigrant community and to produce guidelines for Chagas disease management in primary care settings.

MATERIALS AND METHODS
=====================

A seroprevalence survey of *T. cruzi* infection among the immigrant Bolivian clientele of the primary care clinics of the Brazilian Public Health System (SUS), located in districts of downtown São Paulo, was undertaken.

A sample of 633 volunteers was randomly selected from the clinics patient registry, taking into account an expected prevalence rate of 0.07 with an acceptable error of 0.014 and adding 10% to the sample size to compensate for potential participant losses. The sample included 111 children \< 10 years of age.

*Serological methods* - Infection with *T. cruzi* was defined as a positive result by two serological tests with parasite antigens.

Two commercialised ELISA - based serological tests (Chagas test ELISA III, Bioschile Ingenieria Genetica SA, Santiago, Chile) and ELISA cruzi (BioMerieux Diagnostics SA, Rio de Janeiro, Brazil), which detect antibodies against *T. cruzi* antigens attached to the inner surfaces of microplate wells, were employed according to manufacturer instructions. These tests were repeated in case of discrepant results (positive and negative, or doubtful test result). Confirmatory tests were performed by Tesablot ([@B11]) and recombinant ELISA with trypo and epimastigote antigens (ELISA Chagatest® Wiener Lab, Rosario, Argentina), according to manufacturer instructions.

Sera from the test sample, and positive and negative controls, were applied and incubated at room temperature for 30 min. After washing, chromogenic substrate goat was added and then the reaction was stopped, by adding 1 *N* sulphuric acid. After the addition of the enzyme substrate, the reaction was stopped with stop solution. A positive reaction was defined according to the manufacturer instructions. The reading was performed using a 450 nm filter and a 620-630 nm reference filter.

For immunoblot with trypomastigote antigens, antigen prepared from supernatants of cell culture containing trypomastigotes ([@B11]) were fractionated by polyacrylamide gel electrophoresis (Mini-Protean II; BioRad, Berkeley, CA) and electrophoretically transferred to a nitrocellulose membrane with a porosity of 0.45 µM (BioRad, Berkeley, CA) in a semi-dry system (Hoefer Scientific Instruments, San Francisco, CA). Sera were diluted and incubated for 2 h at room temperature. Antibodies were detected by addition of anti-human IgG labelled with peroxidase (Sigma Chemical St. Louis, MO) and incubated for 1 h and 30 min at room temperature. After the development of the immune-complex by adding 600 μL of solution containing H~2~O~2~, 4-cloro1-naphthol (Sigma Chemical St. Louis, MO), diluted in methanol, the reaction was stopped by adding deionised water. The sample was considered positive when the band of approximately 160kDa was revealed.

*Ethics statement* - The study was conducted in accordance to the principles of the Helsinki Declaration and Brazilian ethical regulations. Selected individuals received a home visit to explain the project and invite them to participate. Those who agreed to participate were asked to sign an informed consent form, answer a questionnaire, and provide a blood sample for analysis. Parents or legal guardians of participants \< 18 years of age provided the informed consent on their behalf. Questionnaires and consent forms were translated into Spanish, and interviews were conducted in Spanish, by Spanish-speaking community health agents. Participants with a diagnosis of *T. cruzi* infection were referred to the primary care clinics of the Brazilian Public Health System for further diagnostic investigation and treatment.

The study protocol was submitted and approved by the research ethics committee of the "Hospital das Clínicas" of the University of São Paulo Medical School (CAPPESQ no. 196.698/2013).

RESULTS
=======

The characteristics of the population sample are presented in [Table I](#t1){ref-type="table"}. The majority of the volunteers were young adults, living in São Paulo for \< 5 years, and were born in the Department of La Paz, Bolivia. Of these, almost 50% reported having lived in the rural areas of Bolivia, and 33.3% had undertaken rural jobs there. A very small proportion of participants were aware of the insect vector causing Chagas disease and reported having been bitten by it.

TABLE ICharacteristics of the study sample, São Paulo (SP), Brazil, 2014Variable(nº)(%)GenderMale29346.3Age\< 1010516.610 - 198513.420 - 2922235.130 - 3915424.340 and more6710.6Time living in SP0 - 1 year13621.52 - 5 years26942.56 - 10 years10216.111 and more12619.9Country of birthBrazil8713.7Other71.1Bolivia53985.2Dept. La Paz41064.8Exposure to Chagas disease and knowledge about itLived in rural zone in Bolivia30948.8Worked in rural jobs in Bolivia21133.3Knows the "vichunca"304.7Found it in household23236.7Has been bitten by "vichunca"304.7Has relatives with Chagas518.1

The prevalence of *T. cruzi* infection was 4.4% (95% confidence interval: 2.8 - 6.0). The distribution of the population sample, according to the variables examined in this study and their association with Chagas infection, is presented in [Table II](#t2){ref-type="table"}.

TABLE IIDistribution of Chagas infection, according to variables examined in this study, São Paulo (SP), Brazil, 2014Variables/Categories*Trypanosoma cruzi* infection - n (%)pNegativePositiveSex0.13 \*Male284 (96.9)9 (3.1) Female321 (94.4)19 (5.6) Age group  0.18 \*\*1 - 9102 (97.1)3 (2.9) 10 - 1983 (97.6)2 (2.4) 20 - 29210 (94.6)12 (5.4) 30 - 39148 (96.1)6 (3.9) 40 and more62 (92.5)5 (7.5) Time living in SP0.49 \*\*0 - 1 year127 (93.4)9 (6.6) 2 - 5261 (97.0)8 (3.0) 6 - 1095 (93.1)7 (6.9) 11 and more122 (96.8)4 (3.2) Country of birth0.02\*\*\*Bolivia511 (94.8)28 (5.2) Brazil and others94 (100.0)- Department of birth (for those born in Bolivia)\< 0.01\*La Paz403 (98.3)7 (1.7) Other108 (83.7)21 (16.3) Lived in rural areas in Bolivia0.12\*Yes291 (94.2)18 (5.8) No252 (96.9)8 (3.1) Worked in rural jobs in Bolivia0.05\*Yes197 (93.4)14 (6.6) No340 (96.9)11 (3.1) Characteristics of house in Bolivia0.38\*Cement90 (98.9)1 (1.1) Clay258 (95.6)12 (4.4) Wood5 (100.0)- Bricks with plaster219 (94.0)14 (6.0) Bricks without plaster33 (97.1)1 (2.9) Knows Chagas disease\< 0.01\*Yes160 (90.4)17 (9.6) No445 (97.6)11 (2.4) Knows the "vichunca"\< 0.01\*Yes210 (90.5)22 (9.5) No395 (98.5)6 (1.5) Has been bitten by the "vichunca"0.05\*\*\*Yes26 (86.7)4 (13.3) No416 (96.1)17 (3.9) Has found the "vichunca" in/around the household\< 0.01\*Yes102 (90.3)11 (9.7) No373 (97.1)11 (2.9) Has relatives with Chagas\< 0.01\*\*\*Yes49 (79.0)13 (21.0) No483 (97.6)12 (2.4) Has received blood transfusion0.51\*Yes27 (93.1)2 (6.9) No578 (95.7)26 (4.3) [^1]

In univariate analysis, variables related to the place of birth were significantly associated with infection. Participants born in Bolivia had an increased risk of infection, compared to participants born in Brazil or another country. Of note, participants born in Brazil or in other countries were mainly children. For participants born in Bolivia, birth in the Department of La Paz was a protective factor, compared to all other Bolivian departments. No participants born in Brazil or in other countries presented the serologic markers of infection. A history of rural jobs in Bolivia was also significantly associated with infection.

Prevalence of infection among women was higher than among men, although the difference was not significant. Except for two cases, all infected women were of childbearing age.

Participants with some knowledge of Chagas disease and those with knowledge of the insect vector had an increased risk of infection. The participants who reported finding the insect vector in or around their home in Bolivia or having been bitten by it were also at increased risk of infection. Furthermore, having relatives with Chagas disease was significantly associated with an increased risk of infection.

Variables associated with infection, with a p value \< 0.10, were analysed using a multivariate logistic regression model in order to identify the variables independently associated with an increased risk of infection ([Table III](#t3){ref-type="table"}). The independent risk factors for infection were: having undertaken rural jobs in Bolivia, knowledge of the vector, and having relatives with Chagas disease. When comparing the birth place of participants, according to the departments in Bolivia, being born in the Department of La Paz was a protective factor.

TABLE IIILogistic regression analysis of factors independently associated with *Trypanosoma cruzi* infection, São Paulo (SP), Brazil, 2014VariablepExp β95% CI Exp βBorn in La Paz Department\< 0.0010.1270.0440.369Worked in rural jobs in Bolivia0.0233.1631.1768.504Knows the "vichunca"0.0243.7491.18911.822Has relatives with Chagas0.0183.4121.2399.398[^2]

DISCUSSION
==========

This is the first serosurvey of *T. cruzi* infection conducted among the Bolivian immigrant community in Sao Paulo, Brazil. The prevalence of infection was slightly lower than the previously reported prevalence among the Bolivian population. Individuals who migrate tend to be younger and healthier than those who do not. Infection was not associated with sex or age. It is noteworthy that three children \< 10 years of age were infected. Two of these were twin brothers; their mother was also infected. Taking into consideration the period that they lived in Brazil, vector transmission in Bolivia, before they moved, could not be excluded.

Knowledge of the "vichunca", the popular name for the insect vector in Bolivia, having relatives with Chagas disease, and a history of rural jobs in Bolivia, were risk factors independently associated with infection. It is likely that these variables indicate proximity to the transmission sites of the parasite. Most of the participants were from the Department of La Paz, where Chagas prevalence is lower than in the other departments of the country. Being born in La Paz Department was a protective factor for infection. Although there are no statistical data on the specific department of origin of Bolivian immigrants, social scientists have highlighted that a large proportion of the immigrant community living in São Paulo came from the Department of La Paz and, specifically, from El Alto, Bolivia's second largest city, located on the outskirts of the capital city. At the start of migration to São Paulo, a sewing industry in El Alto provided experience which later helped the immigrants to find jobs in the garment industry ([@B14]).

A limitation to our study is that the population sample was selected from Bolivian immigrants living in downtown São Paulo and attending primary care services located in this area. The immigrants who registered with the public health system may have already adapted to their new country and may not, therefore, be representative of the general Bolivian community in the city.

Considering the observed prevalence of infection in this study and the estimated number of Bolivian immigrants in São Paulo, between 8,400 and 18,000 Bolivians could be infected by *T. cruzi*. The prevalence of infection among women of childbearing age was 6.1% and maternal-foetal transmission may occur in 4.9% to 6.0% of pregnant women ([@B5]). This would result in 476 - 583 cases of congenital Chagas disease among the Bolivian immigrant community in São Paulo over the next three decades.

At the same time, it is estimated that approximately 1.2 million Brazilians are chronically infected with Chagas disease. Nationwide, the prevalence of the infection among blood donor candidates is declining, and has remained \< 0.3% over the past decade ([@B1], [@B3], [@B12]. It could be argued that the arrival of a few thousand chronically infected immigrants does not substantially change the endemic situation in Brazil. However, since the elimination of household vectorial transmission, the chronically infected Brazilian patients have been ageing. Therefore, the number of pregnant women who are carriers of *T. cruzi* tends to decline and so does the number of infected potential blood and organ donors. Thus, the arrival of young adults and children with chronic infection may pose an additional burden on the Brazilian public health system and its supply of blood and organs.
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[^1]: \*: pearson chi-square; \*\*: chi-square for linear trend; \*\*\*: Fisher exact test.

[^2]: CI: confidence intervals
